This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Liotta, L., Gattozzi, C., Kleinerman, J. et al. Reduction of tumour cell entry into vessels by BCG-activated macrophages. Br J Cancer 36, 639–641 (1977). https://doi.org/10.1038/bjc.1977.242
Issue Date:
DOI: https://doi.org/10.1038/bjc.1977.242
This article is cited by
-
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Cancer and Metastasis Reviews (2007)
-
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma
Oncogene (2002)
-
Hepatocellular injury inhibits lectin-mediated tumor colonization into BALB/c-mice livers
Experientia (1993)
-
A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro
Cancer Immunology Immunotherapy (1992)
-
Therapy of disseminated melanoma by liposome‐activated macrophages
World Journal of Surgery (1992)